|
Volumn 62, Issue 2, 2013, Pages 396-398
|
Effects of exenatide on kidney function, adverse events, and clinical end points of kidney disease in type 2 diabetes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
EXENDIN 4;
PLACEBO;
BLOOD PRESSURE;
BODY WEIGHT;
DOSAGE SCHEDULE COMPARISON;
DRUG DOSE COMPARISON;
DRUG EFFECT;
DRUG SAFETY;
GLOMERULUS FILTRATION RATE;
GLYCEMIC CONTROL;
HUMAN;
INTENTION TO TREAT ANALYSIS;
KIDNEY DISEASE;
KIDNEY FUNCTION;
LETTER;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OUTCOME ASSESSMENT;
TREATMENT OUTCOME;
UNSPECIFIED SIDE EFFECT;
DIABETES MELLITUS, TYPE 2;
DIABETIC NEPHROPATHIES;
FEMALE;
HUMANS;
HYPOGLYCEMIC AGENTS;
KIDNEY;
MALE;
MIDDLE AGED;
PEPTIDES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
VENOMS;
|
EID: 84880627736
PISSN: 02726386
EISSN: 15236838
Source Type: Journal
DOI: 10.1053/j.ajkd.2013.03.026 Document Type: Letter |
Times cited : (24)
|
References (7)
|